Dear Shareholders,The OTC situation is still being resolved and as of this moment, we cannot provide an exact date of when it will recommence trading. We have hired a team that is diligently working with FINRA, as this has postponed planned announcements.
We sincerely apologize for the inconvenience this has caused to our fellow US shareholders, please rest assured that this is our #1 priority and will get solved as soon as possible.